Vaccines for children
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30126D20728
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 75D30126R73375 Solicitation number
- Last date to order 55% complete
- IDV ceiling
- $1,465,091,900.00
- Maximum order
- $1,465,091,900.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention awarded an indefinite-delivery contract to Glaxosmithkline, LLC for vaccines, with a ceiling of $1,465,091,900 and an award date of April 1, 2026. This is a multiple-award vehicle with no set-aside. The contract supports the Vaccines for Children program under Executive Order 14398 and carries an ultimate completion date of March 31, 2027.
Glaxosmithkline is a foreign-owned pharmaceutical manufacturer headquartered in Durham, North Carolina that manufactures vaccines and related pharmaceutical products for federal agencies. The contractor operates as a prime-only vendor without SBA certifications and does not pursue set-aside categories.
Place of performance is not specified in the source materials. The IDIQ procures pediatric and adult vaccines, including routine childhood immunization products, to supply the CDC's Vaccines for Children program. Performance runs from April 1, 2026 through March 31, 2027.
This vehicle is one of multiple IDIQs the CDC maintains for vaccine procurement. Glaxosmithkline's broader federal portfolio centers on the CDC and Department of Veterans Affairs, with additional volume through the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. NAICS 325412 (pharmaceutical preparation manufacturing) and PSC 6840 (Drugs and Biologicals) classify the preponderance of the vendor's federal activity.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $24,999,360 | |
| Funding Only Action | $182,649,494 | |
| Definitize Change Order | $294,030,795 | |
| Other Administrative Action | $0 | |
| Original award | $176,140,645 |
Quick answers
Who was awarded contract 75D30126D20728?
75D30126D20728 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2026.
How much is contract 75D30126D20728 worth?
75D30126D20728's own ceiling is $1,465,091,900. A single order can be worth up to $1,465,091,900.
Who can order from contract 75D30126D20728?
75D30126D20728 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30126D20728 competed?
The extent of competition for 75D30126D20728 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV